Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Citichem India IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 70  to  70 per share
Profile
Min Investment ₹70
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Citichem India Limited, established in 1992, is involved in the procurement and distribution of both organic and inorganic chemicals, bulk drugs, and food chemicals, primarily serving the pharmaceutical industry. The company specializes in the direct supply of specialty chemicals, bulk drugs, and intermediate products, with a diverse range of applications across sectors such as aluminum, steel, textiles, paper, dairy, paints, dyes, soap making, food, adhesives, and pharmaceuticals. Citichem also markets food preservatives and chemicals under its own brand, distributing them through a dedicated team to ensure safe bulk deliveries. Its product offerings include Caustic Soda Flakes, Caustic Soda Lye, Citric Acid Monohydrate, Hydrogen Peroxide, and others. The company operates through various business divisions, including Specialty Chemicals, Intermediates & Active Pharmaceutical Ingredients (API), Food Chemicals, and Laboratory Chemicals. Citichem's strengths lie in its experienced management, scalable business model, commitment to quality and innovation, strategic location, strong relationships with suppliers and customers, and a robust after-sales network. As of June 30, 2024, the company employs nine people. Read More

Basic Info

Face Value 10 per share

Price 70  to  70 per share

P/E (x) 30.4

Sales( Cr.) 54

PAT( Cr.) 1

EPS 2.3

Draft Prospectus --

Exchange BSE-SME

Promoter

Company Promoters

Mr. Arif Esmail Merchant Mr. Hashim Arif Merchant Mrs. Fozia Arif Esmail Merchant 5. Mrs. Saima Hashim Merhant.

Pre Issue Share Holding 99.99%

Post Issue Share Holding 69.99%

Listing Details:

Listing Price: 70

Listing Gain: 0%

Current Price: 18

Gain On Issue: 18 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Dec 27, 2024
Closing Date Dec 31, 2024
Allotment Jan 01, 2025
Refund Jan 02, 2025
Delivery of Shares Jan 02, 2025
Listing Date Jan 03, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 140,000
Retail (Max) 1 2000 140,000
S-HNI (Min) 2 4000 280,000
S-HNI (Max) 7 14000 980,000
B-HNI (Min) 8 16000 1,120,000

Objective of the Issue

1. For Capital expenditure for acquisition of Property. 2. For purchasing of Transportation Vehicles and accessories. 3. For General Corporate Purposes. 4. For meeting the Issue Expenses.

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 900000 250092000 277.9x
Retail 900000 488862000 543.2x
EMP 0 0 0x
Total 1800000 745830000 414.4x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Citichem India Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 127 180 85 21 20 54
Other Income 0 0 0 0 0 0
Total Income 127 180 85 21 20 55
Total Expenditure 127 180 85 20 18 53
Operating Profit 0 0 0 1 2 2
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 0 0 0 1 2 2
Provision for Tax 0 0 0 0 0 0
Profit After Tax 0 0 0 0 1 1
Adjustments 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 1 1
Adjusted Earnings Per Share 28.8 32.3 0.5 0.7 2.8 1.8

Citichem India Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 0 1 6 6 8 20
Minority's Interest 0 0 0 0 0 0
Borrowings 0 0 1 1 1 1
Other Non-Current Liabilities 0 -0 -0 -0 -0 -0
Total Current Liabilities 32 73 85 73 61 49
Total Liabilities 33 73 91 80 69 70
Fixed Assets 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0 8
Total Current Assets 33 73 91 80 69 62
Total Assets 33 73 91 80 69 70

Citichem India Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 1
Cash Flow from Operating Activities 0 0 -6 0 0 -12
Cash Flow from Investing Activities -0 -0 -0 -0 -0 0
Cash Flow from Financing Activities -0 -0 6 -0 -0 15
Net Cash Inflow / Outflow -0 -0 -0 0 0 4
Closing Cash & Cash Equivalent 0 0 0 0 1 4

Citichem India Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 28.76 32.29 0.48 0.73 2.78 1.81
CEPS(Rs) 30.71 35.72 0.52 0.75 2.81 1.82
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 55.74 88.06 11.54 12.27 15.04 29.56
Core EBITDA Margin(%) 0.22 0.12 0.45 2.79 9.14 2.97
EBIT Margin(%) 0.21 0.16 0.5 2.73 9.06 3.62
Pre Tax Margin(%) 0.21 0.16 0.38 2.43 8.72 3.06
PAT Margin (%) 0.15 0.12 0.28 1.73 7.08 2.26
Cash Profit Margin (%) 0.16 0.13 0.31 1.79 7.16 2.27
ROA(%) 0.6 0.41 0.29 0.42 1.86 1.76
ROE(%) 51.61 44.92 7.52 6.09 20.33 8.9
ROCE(%) 36.03 43.9 11.37 8.11 22.44 11.55
Receivable days 5.54 35.98 171.31 702.3 602.9 274.11
Inventory Days 74.9 61.56 162.7 750.38 765.71 146.59
Payable days 92.27 106.7 342.03 1495.96 1489.87 377.2
PER(x) 0 0 0 0 0 14.04
Price/Book(x) 0 0 0 0 0 0.86
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0 0 0.07 0.28 0.28 0.33
EV/Core EBITDA(x) 1.3 0.04 13.6 10.11 3.06 9.2
Net Sales Growth(%) 0 41.47 -52.7 -75.43 -6.37 177.34
EBIT Growth(%) 0 9.41 43.29 34.66 210.44 10.83
PAT Growth(%) 0 12.27 9.02 51.46 282.73 -11.46
EPS Growth(%) 0 12.27 -98.52 51.46 282.74 -34.9
Debt/Equity(x) 0.99 0 0.19 0.18 0.14 0.27
Current Ratio(x) 1.02 1.01 1.08 1.1 1.14 1.27
Quick Ratio(x) 0.2 0.53 0.59 0.48 0.52 1.14
Interest Cover(x) 39.87 89.88 4.13 9 26.76 6.43
Total Debt/Mcap(x) 0 0 0 0 0 0.31

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 170% -14% -16% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -37% NA% NA% NA%
ROE Average 9% 12% 18% 23%
ROCE Average 12% 14% 19% 22%

Company Contact Information

Citichem India Ltd.

7, Floor-1, Plot-96, Dharam Jyoti Kazi Sayed Street, Khand Bazar Masjid Station, Mandvi

IPO Lead Manager(s)

Citichem India Ltd.

Horizon Management Pvt Ltd.

Registrar Info

Citichem India Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp